NCT00984893View on ClinicalTrials.gov

Intra-venous Zoledronic Acid Once Yearly

CompletedOBSERVATIONAL
Enrollment

1,551

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Post-Menopausal Osteoporosis
Interventions
DRUG

zoledronic acid

DRUG

Any oral bisphosphonates marketed in Canada

Trial Locations (3)

Unknown

Vancouver

Hamilton

Groupe de recherche en rhumatologie et maladies osseuses Inc, Québec

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY